New innovations for the treatment of vulvovaginal atrophy: an up-to-date review
V Benini, AF Ruffolo, A Casiraghi, RS Degliuomini… - Medicina, 2022 - mdpi.com
Vulvovaginal atrophy (VVA) is a chronic progressive disease involving the female genital
apparatus and lower urinary tract. This condition is related to hypoestrogenism consequent …
apparatus and lower urinary tract. This condition is related to hypoestrogenism consequent …
Vaginal laser therapy for GSM/VVA: where we stand now–a review by the EUGA Working Group on Laser
S Salvatore, AF Ruffolo, C Phillips, S Athanasiou… - …, 2023 - Taylor & Francis
Vulvovaginal atrophy (VVA) is a chronic progressive condition that involves the genital and
lower urinary tracts, related to the decrease of serum estrogenic levels when menopause …
lower urinary tracts, related to the decrease of serum estrogenic levels when menopause …
Hormone therapy for sexual function in perimenopausal and postmenopausal women
LA Lara, D Cartagena-Ramos… - Cochrane Database …, 2023 - cochranelibrary.com
Background The perimenopausal and postmenopausal periods are associated with many
symptoms, including sexual complaints. This review is an update of a review first published …
symptoms, including sexual complaints. This review is an update of a review first published …
Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index
JE Blümel, P Chedraui, G Baron, E Belzares… - Menopause, 2009 - journals.lww.com
Objective: The purpose of this study was to assess the prevalence of sexual dysfunction
(SD) and associated risk factors among middle-aged Latin American women using one …
(SD) and associated risk factors among middle-aged Latin American women using one …
Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)
DL Barton, JA Sloan, LT Shuster, P Gill, P Griffin… - Supportive Care in …, 2018 - Springer
Background Women with estrogen deficiencies can suffer from vaginal symptoms that
negatively impact sexual health. This study evaluated vaginal dehydroepiandrosterone …
negatively impact sexual health. This study evaluated vaginal dehydroepiandrosterone …
Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial
T Fernandes, LH Costa-Paiva… - The journal of sexual …, 2014 - academic.oup.com
Introduction Female libido is multifactorial and complex. Declining estrogen levels in
postmenopausal women affects vaginal function. Aim The aim of this study was to evaluate …
postmenopausal women affects vaginal function. Aim The aim of this study was to evaluate …
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)
DL Barton, LT Shuster, T Dockter, PJ Atherton… - Supportive Care in …, 2018 - Springer
Background Dehydroepiandrosterone (DHEA) is helpful for treating vaginal symptoms. This
secondary analysis evaluated the impact of vaginal DHEA on hormone concentrations, bone …
secondary analysis evaluated the impact of vaginal DHEA on hormone concentrations, bone …
Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women?
R Mazaro-Costa, ML Andersen… - The journal of sexual …, 2010 - academic.oup.com
Introduction Female sexual dysfunction (FSD) is a complex and multifactorial condition. An
increased incidence of FSD is especially associated with the decline of estrogen. Thus …
increased incidence of FSD is especially associated with the decline of estrogen. Thus …
Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women
TL Griebling, Z Liao, PG Smith - Menopause, 2012 - journals.lww.com
Objective Menopause is often accompanied by vaginal discomfort including burning, itching,
dryness, and spontaneous or provoked pain. Although the direct effects of estrogen …
dryness, and spontaneous or provoked pain. Although the direct effects of estrogen …
Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome
V Martelli, S Valisella, S Moscatiello… - The journal of sexual …, 2012 - academic.oup.com
ABSTRACT Introduction The metabolic syndrome (MetS) is a multifactorial disease
characterized by the co-occurrence of impaired glucose tolerance/diabetes, central obesity …
characterized by the co-occurrence of impaired glucose tolerance/diabetes, central obesity …